Cited 0 times in Scipus Cited Count

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

DC Field Value Language
dc.contributor.authorKu, NS-
dc.contributor.authorLee, SH-
dc.contributor.authorLim, YS-
dc.contributor.authorChoi, H-
dc.contributor.authorAhn, JY-
dc.contributor.authorJeong, SJ-
dc.contributor.authorShin, SJ-
dc.contributor.authorChoi, JY-
dc.contributor.authorChoi, YH-
dc.contributor.authorYeom, JS-
dc.contributor.authorYong, D-
dc.contributor.authorSong, YG-
dc.contributor.authorKim, JM-
dc.date.accessioned2022-01-14T05:19:10Z-
dc.date.available2022-01-14T05:19:10Z-
dc.date.issued2019-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/20100-
dc.description.abstractUnfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were newly introduced as a treatment option for MDR A. baumannii infection. Therefore, we investigated the efficacy of the combination of colistin with fosfomycin and minocycline, respectively, as therapeutic options in MDR A. baumannii pneumonia. We examined a carbapenem-resistant A. baumannii isolated from clinical specimens at Severance Hospital, Seoul, Korea. The effect of colistin with fosfomycin, and colistin with minocycline on the bacterial counts in lung tissue was investigated in a mouse model of pneumonia caused by MDR A. baumannii. In vivo, colistin with fosfomycin or minocycline significantly (p < 0.05) reduced the bacterial load in the lungs compared with the controls at 24 and 48 h. In the combination groups, the bacterial loads differed significantly (p < 0.05) from that with the more active antimicrobial alone. Moreover, the combination regimens of colistin with fosfomycin and colistin with minocycline showed bactericidal and synergistic effects compared with the more active antimicrobial alone at 24 and 48 h. This study demonstrated the synergistic effects of combination regimens of colistin with fosfomycin and minocycline, respectively, as therapeutic options in pneumonia caused by MDR A. baumannii.-
dc.subject.MESHAcinetobacter Infections-
dc.subject.MESHAcinetobacter baumannii-
dc.subject.MESHAnimals-
dc.subject.MESHAnti-Bacterial Agents-
dc.subject.MESHCarbapenems-
dc.subject.MESHColistin-
dc.subject.MESHDisease Models, Animal-
dc.subject.MESHDrug Resistance, Multiple, Bacterial-
dc.subject.MESHDrug Synergism-
dc.subject.MESHDrug Therapy, Combination-
dc.subject.MESHFemale-
dc.subject.MESHFosfomycin-
dc.subject.MESHMice-
dc.subject.MESHMice, Inbred C57BL-
dc.subject.MESHMicrobial Sensitivity Tests-
dc.subject.MESHMinocycline-
dc.subject.MESHPneumonia-
dc.subject.MESHTigecycline-
dc.titleIn vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia-
dc.typeArticle-
dc.identifier.pmid31748527-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868184/-
dc.contributor.affiliatedAuthorChoi, YH-
dc.type.localJournal Papers-
dc.identifier.doi10.1038/s41598-019-53714-0-
dc.citation.titleScientific reports-
dc.citation.volume9-
dc.citation.number1-
dc.citation.date2019-
dc.citation.startPage17127-
dc.citation.endPage17127-
dc.identifier.bibliographicCitationScientific reports, 9(1). : 17127-17127, 2019-
dc.identifier.eissn2045-2322-
dc.relation.journalidJ020452322-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Infectious Diseases
Files in This Item:
31748527.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse